Catalán, José M.
Blanco-Ivorra, Andrea
García-Pérez, José V.
Vales, Yolanda
Martínez-Pascual, David
Ezquerro, Santiago
Garrote, Alicia
Costa, Teresa
Lledó, Luis D.
García-Aracil, Nicolás
Funding for this research was provided by:
Ministry of Universities and European Union (Margarita Salas grant for the training of young doctors)
Research Grants of the Miguel Hernández University of Elche (2022/PER/00002)
Youth Guarantee Plan (EDGJID/2021/075)
Spanish Ministry of Universities (FPU20/05137)
Spanish Ministry of Science and Innovation (IDI-20190764)
Article History
Received: 17 October 2022
Accepted: 30 March 2023
First Online: 11 April 2023
Declarations
:
: The protocol of this study (registration number HLP_35/2021) complies with the Research Ethics Committee of the Hospital La Pedrera of Denia, Spain. Moreover, informed consent was obtained from all subjects involved in the study.
: N.G.A. is founder of Innovative Devices for Rehabilitation and Assistance (iDRhA) while J.M.C. is CEO of iDRhA. The IP protecting the Rubidium technology is licensed to iDRhA.